A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer
about
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer
description
2019 nî lūn-bûn
@nan
2019年の論文
@ja
2019年学术文章
@wuu
2019年学术文章
@zh
2019年学术文章
@zh-cn
2019年学术文章
@zh-hans
2019年学术文章
@zh-my
2019年学术文章
@zh-sg
2019年學術文章
@yue
2019年學術文章
@zh-hant
name
A combinatorial biomarker pred ...... ients with HER2+ breast cancer
@en
type
label
A combinatorial biomarker pred ...... ients with HER2+ breast cancer
@en
prefLabel
A combinatorial biomarker pred ...... ients with HER2+ breast cancer
@en
P2093
P356
P1433
P1476
A combinatorial biomarker pred ...... ients with HER2+ breast cancer
@en
P2093
A C Pavlick
A Contreras
C Gutierrez
C K Osborne
P304
P356
10.1093/ANNONC/MDZ076
P577
2019-06-01T00:00:00Z